Total planned funding: $42,634,424
Allocations
Countries/Regions
| Central Asia Region | $42,634,424 |
Organizational Types
| Own Agency | $14,607,648 |
| University | $7,545,743 |
| NGO | $6,353,170 |
| Unknown | $6,086,114 |
| Host Country Government Agency | $4,997,620 |
| Private Contractor | $2,232,129 |
| Multi-lateral Agency | $645,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $0 |
Program Areas
| Prevention | $12,724,552 |
| Management and Operations | $11,291,678 |
| Governance and Systems | $6,703,892 |
| Care | $4,802,885 |
| Testing | $3,676,372 |
| Treatment | $3,435,045 |
Budget Codes
| HVMS: Management and Operations | $11,291,678 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,341,390 |
| HBHC: Care: Adult Care and Support | $4,175,644 |
| HVCT: Testing: HIV Testing and Counseling | $3,676,372 |
| HTXS: Treatment: Adult Treatment | $3,401,876 |
| HVSI: Strategic Information | $3,025,699 |
| HLAB: Laboratory Infrastructure | $2,516,028 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $2,281,046 |
| OHSS: Health Systems Strengthening | $1,162,165 |
| HMBL: Biomedical Prevention: Blood Safety | $789,905 |
| HVTB: Care: TB/HIV | $627,241 |
| HMIN: Biomedical Prevention: Injection Safety | $312,211 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
USG Aggregated Agencies:
$14,607,648
Countries/Regions
Central Asia Region
| 2010 | $3,180,975 |
| 2011 | $5,099,999 |
| 2015 | $4,926,674 |
| 2017 | $1,400,000 |
Columbia University:
$7,545,743
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2015 | $3,455,000 |
| 2017 | $3,163,000 |
Not Available:
$5,986,114
Countries/Regions
Central Asia Region
| 2010 | $0 |
| 2011 | $1,092,788 |
| 2015 | $4,893,326 |
Population Services International:
$5,312,378
Countries/Regions
Central Asia Region
| 2010 | $0 |
| 2011 | $3,310,994 |
| 2015 | $0 |
| 2017 | $2,001,384 |
Ministry of Health - Kyrgyz Republic:
$2,472,000
Countries/Regions
Central Asia Region
| 2015 | $1,100,000 |
| 2017 | $1,372,000 |